are glp-1 receptor agonists banned by wada 2025 weight-loss drugs a hot health topic. Now, critics are debating whether the medications should be in sports for potentially being performance-enhancing drugs Serena Williams's GLP-1 Shift and
Description
123 Multi agonists In recent years, the development of dual and triple agonists related to GLP-1 has been vigorously pursued

doi: 10.1111/DOM.14997 31 MaXLiuZIlyasILittlePJKamatoDSahebkaAet al
Expert Rev Clin Pharmacol

Exenatide (Byetta) injection [package insert]

Beyond CagriSema, researchers are exploring GLP-1 combined with FGF21 analogues, GLP-1 combined with leptin sensitizers, and even triple or quadruple receptor agonists
